Janne Koskimäki
jankosk@utu.fi |
- Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure (2019)
- Neurosurgery
- Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations (2019)
- Acta Neuropathologica Communications
- Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH) (2019)
- Neurosurgery
- Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth (2018)
- Circulation Research
- Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation (2016)
- European Journal of Drug Metabolism and Pharmacokinetics
- Intracranial Biodegradable Silica-Based Nimodipine Drug Release Implant for Treating Vasospasm in Subarachnoid Hemorrhage in an Experimental Healthy Pig and Dog Model (2015)
- BioMed Research International
- Intracranial Nimodipine Implant: Feasibility and Implications for the Treatment of Subarachnoid Hemorrhage – A Pre-Clinical Study (2015) Koskimäki Janne
- Nimodipine Activates TrkB Neurotrophin Receptors and Induces Neuroplastic and Neuroprotective Signaling Events in the Mouse Hippocampus and Prefrontal Cortex (2015)
- Cellular and Molecular Neurobiology